Thank You!


You have made a smart decision! Please check your email to ensure you don’t miss any of our exciting offers and information.
 
Archives
Tuesday, 20 September 2005 00:00

Clinical Trials Update: Sept. 20, 2005

  • <div class="fb-like" data-send="false" data-layout="button_count" data-width="200" data-show-faces="true" data-font="verdana"
    Tweet

(HealthDay News) — Here are the latest clinical trials, courtesy of CenterWatch:

Sleep Disorders

This study involves two office visits and two over night visits at a sleep clinic in Manhattan over a period of approximately three weeks. You may be eligible if you are between the ages of 18 and 65, are in good health, work night shifts that include 6 hours between 10 p.m. and 8 a.m., work three consecutive nights per week or more, and experience excessive sleepiness during night shifts for at least the past three months. Research site located in New York, NY.

More Information

Please see http://www.centerwatch.com/patient/studies/cat169.html.

—–

Hematologic Cancer

The purpose of this study is to reduce the incidence of grade 2-4 GVHD and WHO grades 3-4 Oral Mucositis. Participants must be 18 years of age or older at time of informed consent and before any study-specific procedure. Research site located in Stanford, Calif.

More Information

Please see http://www.centerwatch.com/patient/studies/cat452.html.

—–

Bowel Dysfunction

Okanagan Clinical Trials is conducting a phase III study to determine the effectiveness of an investigational medication in the treatment of bowel dysfunction in adults taking opioid therapy for persistent, non-cancer pain. Volunteers should be 18 or older and experience bowel dysfunction while taking routine opioid therapy for persistent non-cancer pain. Research site located in Kelowna, Canada.

More Information

Please see http://www.centerwatch.com/patient/studies/cat701.html.

—–

Copyright 2005 CenterWatch. All rights reserved.